Breakthrough Alzheimer’s Drug Rewires the Brain Instead of Just Clearing Plaques

An experimental drug is showing promise by targeting Alzheimer’s disease at the level of gene regulation. Researchers at the University of Barcelona have developed an experimental Alzheimer’s drug that aims at a very different target from today’s approved treatments. Instead of mainly clearing beta-amyloid plaques from the brain, the compound, called FLAV-27, is designed to [...]